Bharat Biotech India covid-19 vaccine track Bharat Biotech India

Covaxin: Indian Covid-19 vaccine maker says recruitment for trials on track

Reading now: 119
www.livemint.com

Also Read | Dark underbelly of India Inc’s shop floorsLocal news reports last week suggested that some of those trial sites were well short of reaching intended recruitment targets.A study at the government-run AIIMS medical institute had only signed up some 200 participants, compared with a goal of 1,500-2,000, Reuters partner ANI reported last week, citing a doctor at the institute.The shot, called COVAXIN, was evaluated in about 1,000 participants in early and mid-stage trials."We are overwhelmed with the steady rise in participation," Bharat Biotech joint Managing Director Suchitra Ella said in a statement on Tuesday.With more than 10 million infections, India, the world's biggest vaccine producing country, is also the second worst-hit.

Read more on livemint.com
The website covid-19.rehab is an aggregator of news from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the news if you find it unreliable.

Related News

DMCA